Allogene Therapeutics Conference Call
The Investor Relations website contains information about Allogene Therapeutics's business for stockholders, potential investors, and financial analysts.
The Allogene Therapeutics Fourth Quarter 2025 Conference Call
The Investor Relations website contains information about Allogene Therapeutics's business for stockholders, potential investors, and financial analysts.
TD Cowen 46th Annual Health Care Conference
The Investor Relations website contains information about Allogene Therapeutics's business for stockholders, potential investors, and financial analysts.
Citi’s 2026 Virtual Oncology Leadership Summit
The Investor Relations website contains information about Allogene Therapeutics's business for stockholders, potential investors, and financial analysts.
Allogene Therapeutics Positions 2026 as a Program-Defining Year for Scalable, Real-World Allogeneic CAR T
1H 2026 Catalyst Stack Anticipated to Validate Scalable, Off-the-Shelf CAR T in Oncology and Autoimmune Disease Interim Futility Analysis of MRD Clearance from the Pivotal Phase 2 ALPHA3 Trial with…
Piper Sandler 36th Annual Healthcare Conference
The Investor Relations website contains information about Allogene Therapeutics's business for stockholders, potential investors, and financial analysts.
The Citizens JMP Hematology and Oncology Summit
The Investor Relations website contains information about Allogene Therapeutics's business for stockholders, potential investors, and financial analysts.